Ledger.Open graph →

SEC Form D · filed January 26, 2018

ALDER BIOPHARMACEUTICALS INC

Offering

$260.3M

Sold

$100.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

BOTHELL, WA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (32)

Randall Schatzman · Bothell, WAExec · Director Paul Carter · Bothell, WADirector Alan B. Montgomery · Bothell, WADirector Mark J. Litton · Bothell, WAExec Deepika B. Pakianathan · Bothell, WADirector James J. Bucher · Bothell, WAExec Clay B. Siegall · Bothell, WADirector Jeffrey J. Smith · Bothell, WAExec Randal J. Hassler · Bothell, WAExec Elisabeth J. Sandoval · Bothell, WAExec Heather B. Preston · Bothell, WADirector Wendy B. Yarno · Bothell, WADirector Paul J. Cleveland · Bothell, WADirector Stephen Dow · Bothell, WADirector Larry J. Benedict · Bothell, WAExec John B. Latham · Bothell, WAExec Randall Schatzman · Bothell, WAExec · Director James J. Bucher · Bothell, WAExec Clay B. Siegall · Bothell, WADirector Jeffrey J. Smith · Bothell, WAExec Paul Carter · Melbourne, Channel IslandsDirector Randal J. Hassler · Bothell, WAExec Elisabeth J. Sandoval · Bothell, WAExec Alan B. Montgomery · Vancouver, WADirector Heather B. Preston · Bothell, WADirector Wendy B. Yarno · Bothell, WADirector Paul J. Cleveland · Bothell, WADirector Stephen Dow · New York, NYDirector Larry J. Benedict · Bothell, WAExec Mark J. Litton · Bothell, WAExec John B. Latham · Bothell, WAExec Deepika B. Pakianathan · Bothell, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗